表紙:バイオ外科手術の世界市場 (2021年~2028年)
市場調査レポート
商品コード
1018761

バイオ外科手術の世界市場 (2021年~2028年)

Global Biosurgery Market - 2021-2028

出版日: | 発行: DataM Intelligence | ページ情報: 英文 180 Pages | 納期: 約2営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=135.89円
バイオ外科手術の世界市場 (2021年~2028年)
出版日: 2021年07月15日
発行: DataM Intelligence
ページ情報: 英文 180 Pages
納期: 約2営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

世界のバイオ外科手術の市場は、患者の効果的な出血管理に対するニーズの拡大などの要因により、今後も拡大傾向が続くと予想されています。また、スポーツ傷害の増加も市場の成長促進につながると考えられています。製品別では骨移植代替品が最大のセグメントとなっています。地域別では北米諸国が最大の市場です。

当レポートでは、世界のバイオ外科手術の市場について分析し、市場規模の動向見通しや、製品別・用途別・地域別の詳細動向、主な市場促進・抑制要因、主要企業のプロファイルなどについて調査しております。

目次

第1章 世界のバイオ外科手術市場:分析手法・範囲

第2章 世界のバイオ外科手術市場:市場の定義と概要

第3章 世界のバイオ外科手術市場:エグゼクティブサマリー

第4章 世界のバイオ外科手術市場:市場力学

  • 市場への影響要因
    • 促進要因
    • 抑制要因
    • 市場機会
    • 影響分析

第5章 世界のバイオ外科手術市場:産業分析

  • ポーターのファイブフォース分析
  • 疫学分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • 償還分析
  • アンメットニーズ

第6章 世界のバイオ外科手術市場:新型コロナウイルス感染症 (COVID-19) の分析

  • COVID-19の市場への影響の分析
    • 「ビフォーコロナ」/過去の市場シナリオ
    • 「ウィズコロナ」/現在の市場シナリオ
    • 「アフターコロナ」/将来の市場シナリオ
  • COVID-19流行中の価格動向
  • 需要・供給の変動域
  • 感染拡大時の市場に対する政府の取り組み
  • メーカー各社の戦略展開状況
  • 結論

第7章 世界のバイオ外科手術市場:製品別

  • イントロダクション
    • 市場規模の分析と対前年成長率 (YoY):製品別
    • 市場求心力指数:製品別
  • 外科用シーラント
    • イントロダクション
    • 市場規模 (金額ベース、2018年~2028年)・対前年成長率 (YoY) (2020年~2028年)
  • 止血剤
  • 癒着防止剤
  • 軟組織アタッチメント
  • 骨移植アタッチメント
  • その他

第8章 世界のバイオ外科手術市場:用途別

  • イントロダクション
  • 一般外科
  • 整形外科
  • 心血管外科
  • 脳神経外科
  • その他

第9章 世界のバイオ外科手術市場:地域別

  • イントロダクション
    • 市場規模 (金額ベース、2018年~2028年)・対前年成長率 (YoY) (2020年~2028年):地域別
    • 市場求心力指数:地域別
  • 北米
    • イントロダクション
    • 域内市場の固有の動向
    • 市場規模・対前年成長率 (YoY):製品別
    • 市場規模・対前年成長率 (YoY):用途別
    • 市場規模・対前年成長率 (YoY):国別
  • 欧州
  • 南米
  • アジア太平洋
  • 中東・アフリカ

第10章 世界のバイオ外科手術市場:競合情勢

  • 主な動向と戦略
  • 企業シェア分析
  • 種類別の相互比較
  • 注目すべき企業
  • 破壊的技術を有する企業
  • スタートアップ企業

第11章 世界のバイオ外科手術市場:企業プロファイル

  • Baxter International Inc.
    • 企業概要
    • 製品の種類/ポートフォリオ/概略
    • 近年の動向
    • 主な財務指標
  • Johnson & Johnson
  • Integra Lifesciences Corporation
  • Becton, Dickinson and Company.
  • B. Braun Melsungen AG
  • CryoLife, Inc.
  • Pfizer
  • Strykers
  • C.R. Bard
  • Sanofi

第12章 DataM Intelligenceについて

目次
Product Code: DMPH3582

Market Overview

The global biosurgery market size was valued US$ XX billion in 2020 and is estimated to reach US$ XX billion by 2028, growing at a CAGR of XX % during the forecast period (2021-2028).

Biosurgery products are used in various surgeries to minimize intra and post-operative complications. Various synthetic and biologic products like anti-adhesive agents, hemostatic agents, surgical sealing agents, bone graft substitutes are utilized in surgeries to prevent excessive blood loss or provide adhesion or wound/tissue healing and repair of damaged or weakened tissues or bones of a body.

Market Dynamics

The growing need for effective blood loss management in patients is expected to drive the market's growth.

One major reason for blood loss in surgery and trauma patients is the ineffective use of traditional wound closure products, such as sutures and staples. Globally, the growing number of accidents has increased the number of surgeries that involve long operating hours. In turn, it has increased the need for effective blood loss management products during surgical procedures. According to a 2019 article published in the National Library of Medicine, uncontrolled hemorrhage is the leading cause of preventable death due to injury. Similarly, according to the National Trauma Institute, after a traumatic injury, hemorrhage is responsible for over 35% of pre-hospital deaths and over 40% of deaths within the first 24 hours of the injury. The number of surgeries that involve long operating times is increasing. In such a scenario, there is a growing demand for effective blood loss management products.

Moreover, different biosurgery products, including hemostatic agents and surgical sealants, are finding substantial adoption as a substitute for conventional sutures and staples during surgeries to control bleeding and cover the wound when conventional products are used impractical. Thus, from the above statements, due to the growing adoption of biosurgery products over conventional products, their use in effectively controlling blood loss drives the growth in the biosurgery market.

The growing number of sports injuries is expected to drive the growth of the market.

According to the John Hopkins Medicine, in 2020, some sports are more dangerous than others. For example, contact sports such as football can be expected to result in a higher number of injuries than a noncontact sport such as swimming. All types of sports have a potential for injury, whether from the trauma of contact with other players or overuse or misuse of a body part. In the U.S., about 30 million children and teens participate in organized sports, and more than 3.5 million injuries each year, which cause some loss of time of participation, are experienced by the participants. Almost one-third of all injuries incurred in childhood are sports-related injuries. By far, the most common injuries are sprains and strains.

Moreover, death from a sports injury is rare; the leading cause of death from a sports-related injury is a brain injury. Sports and recreational activities contribute to approximately 21 percent of all traumatic brain injuries among American children. Almost 50 percent of head injuries sustained in sports or recreational activities occur during bicycling, skateboarding, or skating incidents. More than 775,000 children, ages 14 and younger, are treated in hospital emergency rooms for sports-related injuries each year. Most of the injuries occurred due to falls, being struck by an object, collisions, and overexertion during unorganized or informal sports activities.

The high price of biosurgery products and the rising cost of surgical procedures are expected to hamper the market's growth.

The biosurgery market is extremely competitive in pricing, due to the high competitive intensity among existing players. Most of the products available in this market are priced at a premium. The high cost, coupled with the unfavorable reimbursement scenario for these products in emerging countries, makes them unaffordable for a large section of the target patient population. Due to the high cost of biosurgery products, conventional procedures such as sutures and ligature-based procedures are preferred during surgeries across emerging countries. Also, the biosurgery products currently available in the market are made of complicated reconstitutes with a poor shelf life. Hence, there is a growing need for low-priced products that are easy to handle and have a better shelf life.

COVID-19 Impact Analysis

The COVID-19 pandemic has affected the healthcare systems and has a notable impact on the market. The hospitals became high-risk zones, specifically for patients suffering from chronic conditions. Therefore, non-critical procedures such as elective surgeries were either canceled or postponed during the first and second parts of 2020, which resulted in a significant decline in the total number of elective surgical procedures performed. As a result, the demand for biosurgery products witnessed a sharp decline in 2020. The second wave of COVID-19 further deprioritized elective surgical procedures. Governments across the globe have also issued limitations and bans on medical procedures and elective surgeries. Moreover, the pandemic has resulted in the decline of surgical procedures and is expected to increase in the third quarter of 2021 in countries such as the US. Some countries in the EU have resumed surgical interventions, which has increased the demand for biosurgery products in the region.

Segment Analysis

Bone graft substitute segment is expected to hold the largest market share in this market segment.

The bone graft substitute segment accounted for the largest share in 2020. The segment's growth is attributed to the increasing use of bone graft substitute products in orthopedic and dental surgeries and the significant benefits offered by bone graft substitute products over conventional autograft products. For instance, according to the article(MDPI), in 2021. After tooth loss, bone resorption is irreversible, leaving the area without the adequate bone volume for successful implant treatment. Bone grafting is the only solution to reverse dental bone loss and is a well-accepted procedure required in one in every four dental implants. The various classifications of bone grafts and substitutes, including natural and synthetic materials, are critically present and available as commercial products in each category. Different bone substitute materials, including metals, ceramics, polymers, or their combinations, and their chemical, physical, and biocompatibility properties are utilized.

Moreover, the bone graft substitutes reduce the need to harvest healthy bones from patients to facilitate bone fusion in diseased or surgical bones. In comparison to autografts, the materials used for bone-graft substitutes can be sourced in sufficient quantity in the form of pellets, paste, strips, gels, putty, or blocks. Thus, the bone graft substitute segment is expected to hold the largest market share from the above statements.

Cardiovascular surgery segment is expected to hold the largest market share in this market segment.

The cardiovascular surgery segment dominated the market in 2020. The growth is attributed to the increasing number of cardiac problems and growing healthcare investment. According to the Centers for Disease Control and Prevention (CDC) 2020 data, heart disease is the leading cause of death for men, women, and people of most racial and ethnic groups in the United States. Moreover, One person dies every 36 seconds in the United States from cardiovascular disease, and about 655,000 Americans die from heart disease each year-that's 1 in every 4 deaths. Therefore, an increase in cardiovascular diseases leads to an increase in cardiac surgeries in the forthcoming years. Thus, the cardiovascular surgery segment is expected to hold the largest market share from the above statements.

Geographical Analysis

North America region holds the largest market share in the global biosurgery market.

North America dominated the market with a revenue share in 2020. The growth is attributed to the rising obese patients, cardiovascular diseases, and increasing number of surgeries. For instance, according to the research done by the Harvard T.H. Chan School of Public Health, it is estimated that around 40% of Americans are considered obese, and 18% are considered severely obese as of 2019. Severe obesity is defined as a BMI over 35 in the study. Their projections say that about half of the US population (48.9%) will be considered obese, and nearly 1 in 4 (24.2%) will be considered severely obese by the year 2030. Moreover, the increasing count of geriatrics and the growing healthcare industry, and the rising adoption of advanced surgical tools and devices, substantial investments by governments to strengthen public healthcare delivery are key factors augmenting the market's growth. Thus, from the above statements, the North American region holds the largest market share.

Competitive Landscape

The biosurgery market is vast with presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Johnson & Johnson, Integra Lifesciences Corporation, Baxter International Inc., Becton, Dickinson and Company, B. Braun Melsungen AG, CryoLife, Inc., Pfizer, Strykers, C.R. Bard and Sanofi. The major players are adopting several growth strategies such as Type launches, acquisitions, and collaborations, which are contributing to the growth of the Biosurgery market globally.

Biosurgery Market Key Companies to Watch

Baxter International Inc:

Overview:

Baxter International Inc. is an American multinational health care company with headquarters in Deerfield, Illinois. The company principally focuses on products to treat hemophilia, kidney disease, immune disorders and other chronic and acute medical conditions. Bioscience business produces recombinant and blood plasma proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies and other chronic and acute blood-related conditions; products for regenerative medicine and vaccines. Moreover, the medical products business produces intravenous products and other products used in delivering fluids and drugs to patients; inhalational anesthetics.

¬Product Portfolio:

Baxter International Inc. is into the continuous offering of surgical products. For instance, TISSEEL [Fibrin Sealant] for Surgical Care.

Why Purchase the Report?

  • Visualize the composition of the biosurgery market segmentation by product , application and region highlighting the key commercial assets and players.
  • Identify commercial opportunities in biosurgery market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of biosurgery market- level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players

The global biosurgery market report would provide an access to an approx. 47market data table, 45 figures and 200pages.

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Market Segmentation

Global Biosurgery Market - By Product

  • Surgical Sealants
  • Hemostatic Agents
  • Adhesion Barriers
  • Soft Tissue Attachments
  • Bone Graft Attachments
  • Others

Global Biosurgery Market - By Application

  • General Surgery
  • Orthopedic Surgery
  • Cardiovascular surgery
  • Neurological Surgery
  • Others

Global Biosurgery Market - By Region

  • North America
  • South America
  • Europe
  • Asia
  • Middle East & Africa

Table of Contents

1. Global Biosurgery Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Biosurgery Market - Market Definition and Overview

3. Global Biosurgery Market - Executive Summary

  • 3.1. Market Snippet by Product
  • 3.2. Market Snippet by Application
  • 3.3. Market Snippet by Region

4. Global Biosurgery Market - Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The growing need for effective blood loss management in patients is expected to drive the market's growth.
      • 4.1.1.2. The growing number of sports injuries is expected to drive the growth of the market.
    • 4.1.2. Restraints:
      • 4.1.2.1. The high price of biosurgery products and the rising cost of surgical procedures are expected to hamper the market's growth.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Global Biosurgery Market - Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Epidemiology Analysis
  • 5.3. Supply Chain Analysis
  • 5.4. Pricing Analysis
  • 5.5. Regulatory Analysis
  • 5.6. Reimbursement Analysis
  • 5.7. Unmet Needs

6. Global Biosurgery Market - COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Global Biosurgery Market - By Product

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 7.1.2. Market Attractiveness Index, By Product Segment
  • 7.2. Surgical Sealants*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 7.3. Hemostatic Agents
  • 7.4. Adhesion Barriers
  • 7.5. Soft Tissue Attachments
  • 7.6. Bone Graft Attachments
  • 7.7. Others

8. Global Biosurgery Market - By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application Segment
  • 8.2. General Surgery*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 8.3. Orthopedic Surgery
  • 8.4. Cardiovascular surgery
  • 8.5. Neurological Surgery
  • 8.6. Others

9. Global Biosurgery Market - By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.2.5.1. U.S.
      • 9.2.5.2. Canada
      • 9.2.5.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.3.5.1. Germany
      • 9.3.5.2. U.K.
      • 9.3.5.3. France
      • 9.3.5.4. Italy
      • 9.3.5.5. Spain
      • 9.3.5.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.4.5.1. Brazil
      • 9.4.5.2. Argentina
      • 9.4.5.3. Rest of South America
  • 9.5. Asia Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.5.5.1. China
      • 9.5.5.2. India
      • 9.5.5.3. Japan
      • 9.5.5.4. Australia
      • 9.5.5.5. Rest of Asia Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

10. Global Biosurgery Market - Competitive Landscape

  • 10.1. Key Developments and Strategies
  • 10.2. Company Share Analysis
  • 10.3. Type Benchmarking
  • 10.4. List of Key Companies to Watch
  • 10.5. List of Company with disruptive technology
  • 10.6. List of Start Up Companies

11. Global Biosurgery Market- Company Profiles

  • 11.1. Baxter International Inc.*
    • 11.1.1. Company Overview
    • 11.1.2. Type Portfolio and Description
    • 11.1.3. Key Highlights
    • 11.1.4. Financial Overview
  • 11.2. Johnson & Johnson
  • 11.3. Integra Lifesciences Corporation
  • 11.4. Becton, Dickinson and Company.
  • 11.5. B. Braun Melsungen AG
  • 11.6. CryoLife, Inc.
  • 11.7. Pfizer
  • 11.8. Strykers
  • 11.9. C.R. Bard
  • 11.10. Sanofi

LIST NOT EXHAUSTIVE

12. Global Biosurgery Market - DataM

  • 12.1. Appendix
  • 12.2. About Us
  • 12.3. Contact Us